|
|
U.S.-CHINA PHARMA
May 23-24, 2011|The Hub Cira Center, Philadelphia
|
|
|
|
Featured Speaker:
Wim Vandenhouweele, Executive Director, Global Vaccines and Commercial Development, Merck & Co.
Since joining Merck over 28 years ago, Mr. Vandenhouweele has held regional, national, and global positions to identify commercial opportunities worldwide and understands how important it is for today's U.S. bio-pharma leaders to remain competitive in the Chinese market. |
|
|
|
Greetings!
U.S.-CHINA PHARMA is the new industry meeting place for those who want to navigate emerging licensing opportunities in China.
Join us on May 23-24 in Philadelphia to learn about new strategic operations to increase R&D productivity; explore academic/industrial partnerships; debate product and globalization strategies; and uncover China's R&D capabilities and landscape.
Networking activities throughout the event will allow you to get in front of potential partners and ensure you stay competitive in this emerging market.
|
|
|
Featured Panels on In/Out-Licensing:
EMERGING LICENSING OPPORTUNITIES IN CHINA
- Wei Zhang, Ph.D., Principal, Safeguard Scientifics
- Rajeev Dadoo, Partner, SR One
- John Jin, Vice President, Business Development, TaiGen (Taiwan)
- Mike Liu, Head of Global Business Development, Hengrui Pharmaceuticals (China)
- Geoff Meyerson, Founder and Managing Director, Locust Walk Partners
IDENTIFYING OUTSOURCING AND PARTNERSHIP OPPORTUNITIES FOR BOTH SMALL AND LARGE LIFE SCIENCE COMPANIES R&D PROJECTS
- Dr. Yuan-Hua Ding, Senior Director & Head of External R&D Innovation - Asia, PFIZER WORLDWIDE RESEARCH AND DEVELOPMENT
- Christopher Laing, MRCVS, Ph.D., Vice President, Science and Technology, UNIVERSITY CITY SCIENCE CENTER
- Drew Natenshon, Head US Research Strategy and Operations, NOVARTIS VACCINES & DIAGNOSTICS
|
|
Featured Panels on Academic/Industrial Partnership:
HOW TO SUSTAIN LIFE SCIENCE RESEARCH IN CHINA - STRENGTHENING THE ACADEMIC COLLABORATION BETWEEN US AND CHINA
- Wei Zhou, M.D., Ph.D., Director, Molecular Epidemiology Pfizer Oncology; Co-Chair of Academic Relationships US CHINESE ANTI-CANCER ASSOCIATION
- David Christiani, M.D., M.P.H., M.S., Elkan Blout Professor of Environmental Genetics, Department of Environmental Health and Epidemiology, HARVARD SCHOOL OF PUBLIC HEALTH
- Qingyi Wei, M.D., Ph.D., Professor of Epidemiology, UNIVERSITY OF TEXAS M.D. ANDERSON CANCER CENTER
EARLY LICENSING TO FEED CHINA'S R&D PIPELINE
- Melvin Reichman, Ph.D., Director, LIMR Chemical Genomics Center (LCGC)
- Annette Tobia, Ph.D., J.D., Founder and CEO, Dynamis Therapeutics and Dynamis Skin Science
- Patricia weeks, Founder and President, Weeks Consulting LLC
|
|
|
If you are interested in sponsoring, exhibiting, or speaking opportunities, please contact Judy Tsui (twee) at judy@cypinproduction.com or call 917.338.7778.
|
|
Sincerely,
Judy Tsui
Cypin Production LLC
|
|
|
|
|
Academic, Government & NGO Specials
| You may be eligible for a special pricing if you are a representative from academic, government, and NGOs. Please send an email to info@cypinproduction.com for details and to check eligibility.
| | Offer Expires: MARCH 16, 2011 |
|
|
